Growth lending explained
A map of the debt market for high-growth companies: where venture debt, growth credit, bank lending and private credit overlap, where they differ, and what borrowers should examine beyond the label.
In brief
- Growth lending is a broad label for loans to high-growth companies, including venture debt and growth credit.
- The same product name can hide very different repayment assumptions, costs and restrictions, so compare the documents rather than the label.
- Debt may reduce dilution, but interest and repayments still fall due if growth is weaker than planned.
- A facility should leave enough liquidity and flexibility to survive a reasonable downside, not only the board plan.
In this guide
- What Undiluted means by growth lending
- The market map
- How the underwriting changes as a company matures
- What a growth-lending facility can look like
- What growth companies use the money for
- The cost is more than the interest rate
- Benefits and risks
- Where growth lending sits within private credit
- How to compare lenders when the terminology moves
- Where to go next
- The bottom line
The market has more product names than distinct forms of risk. Two lenders can offer almost the same facility and call one venture debt and the other growth credit. Two facilities carrying the same label can be underwritten against entirely different sources of repayment.
That makes the label a useful starting point and a poor basis for a financing decision. The useful questions are more concrete: who is borrowing, what will repay the loan, what security and controls the lender receives, how the facility behaves if growth slows, and whether undrawn capital is genuinely available when it is needed.
What Undiluted means by growth lending
We use the term deliberately. Conventional corporate debt is usually explained through assets, established cash flow and leverage. Growth companies may be asset-light, loss-making by choice, reinvesting most of their gross profit, or too young to have a long trading history. Specialist lenders therefore combine ordinary credit analysis with evidence that is more useful at that stage: recurring revenue, retention, unit economics, cash runway, investor support, enterprise value and the probability of reaching a refinancing or equity milestone.
Growth lending is not synonymous with private credit. A bank can provide venture debt or another growth facility. Private credit, in the usual institutional sense, refers to privately negotiated credit originated or held by non-bank lenders. The categories overlap when a private credit fund lends to a growth company, but neither fully contains the other.
The product name tells you who the lender hopes to serve. The repayment case tells you what you are actually buying.
The market map
| Label | Typical borrower | Main underwriting emphasis | Where the boundary blurs |
|---|---|---|---|
| Venture debt | Venture-backed, often early or expansion stage; may be pre-profit | Runway, investor quality and support, future fundraising, milestones and sometimes recurring revenue | Some lenders use venture debt for much later-stage, revenue-scale businesses |
| Growth credit or growth debt | Later-stage private growth company; often meaningful recurring revenue and closer to, or already at, profitability | Revenue quality, enterprise value, path to cash generation, sponsor support and downside liquidity | May be marketed as venture debt, recurring-revenue lending or direct lending |
| Bank growth lending | Growth company that also fits a bank’s risk, relationship and regulatory constraints | Deposits and relationship, recurring revenue, receivables, sponsor support, assets or cash flow depending on product | A bank venture-debt desk may underwrite much like a specialist fund |
| Direct lending | Usually an established middle-market company, frequently private-equity backed | Cash flow, EBITDA, leverage, debt-service capacity and enterprise value | Growth-credit funds can describe their work as a specialist form of direct lending |
| Asset-based or working-capital finance | Company with receivables, inventory, equipment or other financeable assets | Collateral quality, advance rates, collections and borrowing-base controls | Can fund growth, but the risk is anchored to assets rather than the growth thesis |
The most important distinction in that table is not venture debt versus growth credit. It is the source of repayment. At one end, a lender expects the company to raise more equity before the loan matures. At the other, it expects operating cash flow to service and ultimately repay the debt. Between them sits a wide range of facilities supported by recurring revenue, enterprise value, sponsor capital and a credible path to profitability.
How the underwriting changes as a company matures
Earlier stage: runway and investor support
An early-stage borrower may have little revenue, no profit and few assets that would matter in an enforcement. A venture debt lender pays close attention to the recent equity round, the quality and reserves of the investor syndicate, cash burn, the milestones the new capital should fund and the likelihood of another round. The loan is still debt, but part of the underwriting and repayment thesis may be continued access to equity.
Scaling stage: the quality of revenue
Once a company has meaningful revenue, underwriting shifts towards its durability. Contract length, renewal rates, gross and net retention, customer concentration, gross margin, billing terms and cash collection become central. Annual recurring revenue is not cash flow, but predictable revenue can support a view of future cash generation and enterprise value that a lender can monitor.
Later stage: cash flow and leverage
A profitable or near-profitable growth company begins to resemble a conventional corporate credit. EBITDA, leverage, interest coverage, free cash flow and the value of the business in a downside carry more weight. At that point, growth credit can converge with direct lending even if the company remains founder-led, technology-heavy and faster-growing than a typical middle-market borrower.
What a growth-lending facility can look like
Growth lending is a market category, not a single instrument. Facilities are usually built from familiar debt components, arranged to fit a less mature or faster-changing borrower.
- A term loan drawn at closing, often with an initial interest-only period followed by amortisation or a bullet repayment.
- A delayed-draw or tranched facility, with later amounts available only during a draw period and sometimes subject to revenue, equity-raise or other performance conditions.
- A revolving line sized against recurring revenue, receivables or another borrowing base, used for working capital rather than long-term runway.
- A bespoke acquisition, equipment or capital-expenditure facility where the use and repayment of the money are more tightly defined.
The loan may be senior secured over substantially all assets, although the security package depends on jurisdiction, product and lender.
Pricing may be fixed or floating. Covenants may test minimum cash, liquidity, revenue, ARR, EBITDA or leverage; some facilities have no maintenance financial covenant but still contain reporting obligations, restrictions on additional debt and liens, and events of default.
Warrants or another equity participation are common in some parts of venture and growth debt and absent in others.
None of those features should be assumed from the product name. “Covenant-lite” does not mean covenant-free. “Non-dilutive” may ignore warrants. A £10 million commitment is not £10 million of usable liquidity if most of it depends on conditions the operating plan has not yet met.
What growth companies use the money for
Debt works best when the use of proceeds is bounded and the company can explain how the investment improves its capacity to repay. Common uses include extending runway after an equity round, funding sales or product investment with observable payback, financing equipment or research and development, supporting working capital, making an acquisition and refinancing an existing facility.
| Use | Potential fit | What must be true |
|---|---|---|
| Extend runway to a defined milestone | Often suitable | The milestone is achievable before liquidity becomes tight, and missing it does not make repayment impossible |
| Scale a repeatable sales engine | Potentially suitable | Unit economics, retention and sales payback are evidenced rather than assumed |
| Fund an acquisition | Potentially suitable | Integration risk, synergies and downside liquidity are modelled; the facility is not relying on perfect execution |
| Bridge an imminent equity round | High execution risk | The round is genuinely advanced and the company can survive delay or repricing |
| Find product-market fit | Usually unsuitable | There is no predictable repayment source; equity is designed to absorb this uncertainty |
| Cover an unresolved structural cash shortfall | Usually unsuitable | Debt postpones rather than fixes the underlying problem |
The cost is more than the interest rate
A growth facility can be cheaper than issuing equity if the company performs well, but that does not make the debt cheap. Compare offers using the total cash and control cost across the expected life of the facility.
- Cash interest: the reference rate or base rate, any floor and the lender’s margin.
- Fees: arrangement, commitment, non-utilisation, monitoring, end-of-loan, prepayment and amendment fees.
- Equity participation: warrants, success fees or other instruments whose value rises with the company.
- Execution cost: lender and borrower legal fees, diligence and the management time required to close and report.
- Optionality lost: prepayment protection, restrictions on future debt or acquisitions, and the cost of maintaining covenant headroom.
Benefits and risks
| Feature | Potential benefit | Corresponding risk |
|---|---|---|
| Fixed repayment claim | Less dilution if enterprise value grows | Principal and interest remain due if enterprise value falls |
| Interest-only period | Preserves cash early in the term | Can create a sharp increase in debt service when amortisation starts |
| Tranches | Avoids paying interest before money is needed | Later capital may disappear when performance weakens |
| Covenants and reporting | Can impose useful discipline and early warning | A miss may give the lender control when the company has least negotiating leverage |
| Security | Makes specialist lending possible at lower pricing than unsecured risk | Enforcement can affect the whole business, including intellectual property |
| Warrants | Can reduce the required cash return | Creates dilution and valuation complexity that is easy to understate |
The practical test is not whether debt is cheaper than equity in the success case. It is whether the company can preserve enough liquidity and decision-making room in a reasonable downside. A facility that works only at 100% of plan is not financing the plan; it is financing the absence of variance.
Where growth lending sits within private credit
Private credit is commonly used for non-bank credit negotiated directly between a borrower and a lender or small club of lenders. It includes direct lending, real-estate and infrastructure debt, asset-based finance, distressed and special-situations strategies, and venture debt. Direct lending is one strategy within that broader asset class, usually associated with performing middle-market companies and cash-flow underwriting.
Growth credit can therefore be described as a segment of private credit when a fund is the lender. Venture debt can sit inside private credit when originated by a non-bank fund and outside it when provided by a bank. Growth lending, as Undiluted uses the term, cuts across that institutional boundary because a founder or CFO is usually choosing among facilities, not allocating to an asset class.
How to compare lenders when the terminology moves
Ask every lender the same questions and compare the answers, regardless of what appears on the product page.
- What is the primary source of repayment in your credit paper: cash flow, recurring revenue, enterprise value, collateral or future equity?
- Which parts of the commitment are available at closing, and which depend on later conditions or lender discretion?
- What happens to liquidity, covenants and amortisation if revenue is 20% below plan for two quarters?
- What is the total cash cost under the expected draw and repayment schedule, including all fees and prepayment protection?
- What equity participation, board observation, reporting, consent and transfer rights accompany the loan?
- How has the lender handled comparable borrowers after a covenant breach, delayed fundraise or missed plan?
Where to go next
- Venture debt explained covers the earlier-stage product, facility structure and borrower fit in detail.
- Who lends to growth companies maps the different lender types and the incentives behind them.
- Debt or equity: choosing between them deals with the capital-structure decision before a lender process begins.
- Reading a debt term sheet explains how to compare the actual terms once offers arrive.
The bottom line
Growth lending is best understood as a continuum. Venture backed runway finance sits at one end; cash-flow direct lending sits at the other; growth credit, recurring-revenue facilities and specialist bank products occupy the space between them. Market participants draw the boundaries differently.
For a borrower, precision comes from the documents rather than the category. Identify the lender’s repayment case, model the downside, value the whole economic package and treat conditional capital as conditional. Once those points are clear, the name on the facility matters much less.
The Stack
Venture debt and growth credit intelligence, in your inbox every Tuesday.
Continue learning
What is venture debt?
Venture debt is a loan for venture backed growth companies. This guide explains who uses it, how it works, what it costs and when the risks may outweigh the benefits.
Continue